PEM as a starting point to study ME/CFS
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at how post-exertional malaise (PEM) affects people with ME/CFS. It aims to understand the condition better and find new ways to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing and able to complete all study tasks
- You must be able to give your informed consent
- If you have ME/CFS, you must meet the International Consensus Criteria (ICC) or Canadian Consensus Criteria (CCC)
- You must have a history of persistent fatigue and post-exertional malaise (PEM) that started suddenly or got worse over 6 months
- You cannot have used immune-modulating drugs in the past 3 months
- You cannot have a serious medical condition that could explain your symptoms, such as cancer, heart disease, uncontrolled diabetes, or autoimmune diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how chronic infections and inflammation affect people with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) compared to healthy people. Researchers want to understand what causes symptoms and find better ways to help.
This trial tests whether a specific mind-body program can help people with Long COVID or ME/CFS feel better. It compares the program to standard care to see if it improves symptoms like fatigue and brain fog.
This study is testing a way to improve medical care for people with ME/CFS (including post-COVID ME/CFS) who are mostly homebound. The goal is to see if bringing healthcare to your home helps you better manage your condition.
This study is tracking children, teens, and young adults (up to age 25) who developed ME/CFS after an infection. It aims to better understand the condition in younger people.
This trial studies how people with ME/CFS respond to an exercise test. It may help researchers understand what kind of exercise response is typical and how it relates to symptoms.
This study observes how a blood-cleaning treatment called immunoadsorption works in patients with ME/CFS (severe fatigue condition) who have specific immune markers. Researchers will track whether this treatment helps reduce symptoms and improve daily functioning.
Hear when a new Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.